Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
3.330
-0.040 (-1.19%)
At close: Jul 18, 2025, 4:00 PM
3.440
+0.110 (3.30%)
After-hours: Jul 18, 2025, 5:47 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $50.02 million as of July 18, 2025. Its market cap has decreased by -85.67% in one year.
Market Cap
50.02M
Enterprise Value
5.09M
1-Year Change
-85.67%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $50.02M, a decrease of -59.25%. That is a compound annual growth rate of -15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 50.62M | -84.22% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |